Colleen Delaney
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Colleen Delaney
Colleen Delaney is recorded as CFO at Z Squared Inc. (ZSQR). Z Squared Inc. reported in an 8-K filed March 27, 2025 that Colleen Delaney resigned as Chief Scientific and Medical Officer, effective March 24, 2025. The proxy statement of Z Squared Inc. reports total compensation of $150,999 for Colleen Delaney in fiscal 2023, including a base salary of $150,999. Disclosed compensation is on record for 2 fiscal years.
“On March 21, 2025, Colleen Delaney submitted her resignation from her role as Chief Scientific and Medical Officer of the Coeptis Therapeutics Holdings, Inc. (the "Company"), effective March 24, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Z Squared Inc.
Other people whose current roles at this company are on record from its filings.
- David Halabu CEO, Board Member
- David Mehalick CEO, Chairman, Board Member
- Michelle Burke CEO, COO, Board Member
- Robert Striar CEO, Board Member
- Brian Cogley CFO
- Christopher Calise CFO, Board Member
- Jeffery Harris CTO
- Jeffrey Harris CTO
- Adam Sohn Board Member
- Baron Davis Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Z Squared Inc. (ZSQR) | Chief Financial Officer Christine Sheehy\ Former Chief Financial Officer | $150,999 | $150,999 |
| 2022 | Z Squared Inc. (ZSQR) | Chief Financial Officer Christine Sheehy\ Former Chief Financial Officer | $150,999 | $225,999 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.